Liberate Bio
Latest round
- Seed
Last raised
- Oct 2025
Total raised
- $31M
Investors
- 1
About Liberate Bio
Founded in 2022, Liberate Bio is headquartered in Boston, US, and specializes in advanced genetic therapies.Liberate Bio specializes in advanced genetic medicine delivery through its proprietary RAPTOR™ platform. This innovative system is designed to facilitate extrahepatic delivery of genetic therapies at an unmatched industrial scale, thereby enhancing the efficacy and reach of mRNA, CRISPR, and gene editing technologies. The key end use cases being addressed by the company include the treatment of various genetic disorders and enhancing the therapeutic potential of genetic medicines. Liberate Bio's client base primarily includes biopharmaceutical companies and research institutions engaged in genetic therapy development.Liberate Bio generates revenue through partnerships with biopharmaceutical companies that utilize the RAPTOR™ platform for their genetic medicine development needs. The company's transaction structure is primarily B2B, focusing on collaborations and licensing agreements to enable other firms to leverage its delivery technology. These partnerships may involve milestone payments and royalties based on the success of developed therapies utilizing the RAPTOR™ platform. Specific pricing plans and contract terms are tailored to each partnership and are informed by the unique value proposition of the RAPTOR™ technology, which is designed to optimize the delivery of genetic treatments. Plans for growth include launching new products focused on enhancing genetic therapy delivery and expanding into additional markets in North America and Europe by 2026.
Who invested in Liberate Bio
1 investor across 1 round
See all investors in Liberate Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 15, 2025
Amount
$31M
Investors
Questions about Liberate Bio
Who invested in Liberate Bio?
Liberate Bio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Liberate Bio raised?
Liberate Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Liberate Bio last raise money?
Liberate Bio's most recent round on record is a Seed, in Oct 2025.
What does Liberate Bio do?
Founded in 2022, Liberate Bio is headquartered in Boston, US, and specializes in advanced genetic therapies.
Where is Liberate Bio headquartered?
Liberate Bio is headquartered in Boston, US.
Which VCs invest in companies like Liberate Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Liberate Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Liberate Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.